1. Home
  2. HAIN vs SCLX Comparison

HAIN vs SCLX Comparison

Compare HAIN & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hain Celestial Group Inc. (The)

HAIN

Hain Celestial Group Inc. (The)

HOLD

Current Price

$1.29

Market Cap

95.1M

ML Signal

HOLD

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$8.68

Market Cap

90.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HAIN
SCLX
Founded
1993
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
95.1M
90.0M
IPO Year
1993
N/A

Fundamental Metrics

Financial Performance
Metric
HAIN
SCLX
Price
$1.29
$8.68
Analyst Decision
Hold
Hold
Analyst Count
9
1
Target Price
$2.91
N/A
AVG Volume (30 Days)
2.0M
81.3K
Earning Date
02-09-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,533,067,000.00
$40,360,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$0.39
$749.70
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$3.60
52 Week High
$5.66
$34.27

Technical Indicators

Market Signals
Indicator
HAIN
SCLX
Relative Strength Index (RSI) 58.78 25.49
Support Level $1.13 $10.35
Resistance Level $1.32 $12.30
Average True Range (ATR) 0.09 1.05
MACD 0.01 -0.16
Stochastic Oscillator 72.60 1.55

Price Performance

Historical Comparison
HAIN
SCLX

About HAIN Hain Celestial Group Inc. (The)

The Hain Celestial Group Inc is a health and wellness company. It makes natural and organic food and personal-care products. The company offers products across various categories such as snacks, baby & kids food, beverages, meal preparation, and personal care through brands like Garden Veggie Snacks, Terra chips, Garden of Eatin snacks, Hartley's Jelly, and Celestial Seasonings teas, among others. It operates under two reportable segments: North America and International. The majority of its revenue is derived from the North America segment, which represents the sale of its products in the United States and Canada. The International segment includes the sale of its products in the United Kingdom and the Western European region.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.

Share on Social Networks: